01Jan FDA rejects Corcept’s rare hormonal disorder drug The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal disorder, the company said on Wednesday. Shares of the drugmaker… Read More
